Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma

Journal of Molecular Diagnostics

Volumn 6, Issue 4, 2004, Pages 326-334

  Xue, Wei Cheng ^a   Chan, Kelvin Y K ^a   Feng, Hui Chen ^a   Chiu, Pui Man ^a   Ngan, Hextan Y S ^a   Tsao, Sai Wah ^a   Cheung, Annie N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEATH ASSOCIATED PROTEIN KINASE; GLUTATHIONE TRANSFERASE; PROTEIN P16; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN;

ADULT; ARTICLE; CARCINOGENESIS; CHORIOCARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLACENTA; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLASTIC TUMOR;

EID: 8744242129     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60528-4     Document Type: Article

References (46)

1. Paradinas FJ, Elston CW: Gestational trophoblastic diseases. Haines & Taylor Obstetrical and Gynaecological Pathology. Edited by Fox H, Wells M. Edinburgh, Churchill Livingstone, 2003, pp 1359-1430
2. Shih IM, Mazur MT, Kurman RJ: Gestational trophoblastic disease and related lesion. Blaustein's Pathology of the Female Genital Tract. Edited by Kurman RJ. New York, Springer Verlag, 2002, pp 1193-1247
3. Li HW, Tsao SW, Cheung AN: Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 2002, 23:20-31
4. Cheung AN: Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 2003, 17:849-868
5. Yang X, Zhang Z, Jia C, Li J, Yin L, Jiang S: The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole. Gynecol Oncol 2002, 85:438-444
6. Kim YT, Cho NH, Ko JH, Yang WI, Kim JW, Choi EK, Lee SH: Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts. Cancer 2000, 89:673-679
7. Fulop V, Colitti CV, Genest D, Berkowitz RS, Yiu GK, Ng SW, Szepesi J, Mok SC: DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene 1998, 17:419-424
8. Stahle-Backdhal M, Inoue M, Zedenius J, Sandstedt B, DeMarco L, Flam F, Silfversward C, Andrade J, Friedman E: Decreased expression of Ras GTPase activating protein in human trophoblastic tumors. Am J Pathol 1995, 146:1073-1078
9. Cheung AN, Zhang DK, Liu Y, Ngan HY, Shen DH, Tsao SW: Telomerase activity in gestational trophoblastic disease. J Clin Pathol 1999, 52:588-592
10. Chiu PM, Ngan YS, Khoo US, Cheung AN: Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology 2001, 38:243-249
11. Wong SY, Ngan HY, Chan CC, Cheung AN: Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod Pathol 1999, 12:1025-1033
12. Vegh GL, Selcuk TZ, Fulop V, Genest DR, Mok SC, Berkowitz RS: Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol 1999, 75:248-253
13. Xue WC, Feng HC, Tsao SW, Chan KY, Ngan HY, Chiu PM, MacCalman CD, Cheung ANY: Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Int J Gynecol Cancer 2003, 13:879-888
14. Arima T, Matsuda T, Takagi N, Wake N: Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet 1997, 93:39-47
15. Hube F, Reverdiau P, Iochmann S, Rollin J, Cherpi-Antar C, Gruel Y: Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells. Biol Chem 2003, 384:1029-1034
16. Kanduri C, Kanduri M, Liu L, Thakur N, Pfeifer S, Ohlsson R: The kinetics of deregulation of expression by de novo methylation of the h19 imprinting control region in cancer cells. Cancer Res 2002, 62:4545-4548
17. Lai CYL, Chan KY, Khoo US, Ngan HY, Xue WC, Chiu PM, Tsao SW, Cheung ANY: Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol 2004, 17: 40-48
18. Wong LC, Ngan HY, Cheng DK, Ng TY: Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol 2000, 183:1579-1582
19. Chan KY, Ozcelik H, Cheung AN, Ngan HY, Khoo US: Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res 2002, 62:4151-4156
20. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-9826
21. Lee S, Kim WH, Jung HY, Yang MH, Kang GH: Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am J Pathol 2002, 161:1015-1022
22. Lo AK, Liu Y, Wang XH, Huang DP, Yuen PW, Wong YC, Tsao GS: Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest 2003, 83:697-709
23. Dong SM, Kim HS, Rha SH, Sidransky D: Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 2001, 7:1982-1986
24. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific-inhibition of cyclin-D/Cdk4. Nature 1993, 366:704-707
25. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG: Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 2000, 60:129-133
26. Konishi N, Nakamura M, Kishi M, Nishimine M, Ishida E, Shimada K: Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas. Am J Pathol 2002, 160:1207-1214
27. Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD, Yang CS: Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999, 5:2704-2713
28. Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH, Goggins M: Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 2002, 160:1573-1581
29. Bian YS, Yan P, Osterheld MC, Fontolliet C, Benhattar J: Promoter methylation analysis on microdissected paraffin-embedded tissues using bisulfite treatment and PCR-SSCP. Biotechniques 2001, 30: 66-72
30. Fu C, Zhang Q, Lu F, Zhang Z, Hu Y, Lin L: The expressions of p16, CDK4 and PCNA proteins in trophoblastic tumors. Hunan Yi Ke Da Xue Xue Bao 1998, 23:17-20
31. Janneau JL, Maldonado-Estrada J, Tachdjian G, Miran I, Motte N, Saulnier P, Sabourin JC, Cote JF, Simon B, Fredman R, Chaouat G, Bellet D: Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab 2002, 87:5336-5339
32. Li HW, Cheung AN, Tsao SW, Cheung AL, O WS: Expression of e-cadherin and beta-catenin in trophoblastic tissue in normal and pathological pregnancies. Int J Gynecol Pathol 2003, 22:63-70
33. Bass KE, Li H, Hawkes SP, Howard E, Bullen E, Vu TK, McMaster M, Janatpour M, Fisher SJ: Tissue inhibitor of metalloproteinase-3 expression is up-regulated during human cytotrophoblast invasion in vitro. Dev Genet 1997, 21:61-67
34. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung HF, Colburn NH, Sun Y: Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 1996, 17:1805-1811
35. Langton KP, Barker MD, McKie N: Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. J Biol Chem 1998, 273:16778-16781
36. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B: A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003, 9:407-415
37. Ahonen M, Baker AH, Kahari VM: Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998, 58:2310-2315
38. Bond M, Murphy G, Bennett MR, Newby AC, Baker AH: Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. J Biol Chem 2002, 277: 13787-13795
39. Kang SH, Choi HH, Kim SG, Jong HS, Kim NK, Kim SJ, Bang YJ: Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by DNA hypermethylation of the 5′-CpG island in human gastric cancer cell lines. Int J Cancer 2000, 86:632-635
40. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD: Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001, 61:249-255
41. Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB, Gabrielson E: Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene 1998, 16:2159-2164
42. Melki JR, Vincent PC, Clark SJ: Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia. Leukemia 1999, 13:877-883
43. Rood BR, Zhang H, Weitman DM, Cogen PH: Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res 2002, 62:3794-3797
44. Yamanaka M, Watanabe M, Yamada Y, Takagi A, Murata T, Takahashi H, Suzuki H, Ito H, Tsukino H, Katoh T, Sugimura Y, Shiraishi T: Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 2003, 106:382-387
45. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 2001, 61:3225-3229
46. Ogi K, Toyota M, Ohe-Toyota M, Tanaka N, Noguchi M, Sonoda T, Kohama G, Tokino T: Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 2002, 8:3164-3171